CEO Shareholder Letter and Quarterly Report Dear Shareholder, link here As we conclude another quarter, it’s appropriate that I bring you, our owners, up-to-date on the progress Avita has made in recent months. US Approval Program Update The big goal that our team is working towards is entry to the US market, and I am […]
Thursday, November 10, 2016 5:27 pm EST – link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB US03211P1030 “AmpliPhi has made tremendous progress this quarter, demonstrated by the announcement of topline data from clinical trials of both of our lead development programs, including the first U.S.-based trial of AB-SA01” SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation […]
CATEGORY: Featured Thursday, November 17, 2016 8:45 am EST – link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB US03211P1030 SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a biotechnology company focused on the discovery, development and commercialization of novel phage therapeutics, today announced the pricing of an underwritten public offering of 5,335,000 shares of its […]
Digital health technology company, Adherium Limited, has appointed Scott Fleming as Senior Vice President of Business Development, Europe with immediate effect. – link here Background Adherium is a provider of digital health solutions to patients, pharmaceutical companies, healthcare providers and contract research organizations. Boasting the broadest range of “smart” medication sensors for respiratory medications globally, […]
Digital monitoring device proven to increase adherence and reduce hospital visits – link here The National Institute for Clinical Excellence (NICE) has recognised digital platform Smartinhaler as the most effective means of improving asthma medication adherence in new guidance. The Medtech Innovation Briefing – designed to accelerate NHS access to innovation in new treatments and […]
23 February 2017: Adherium Limited (ASX : ADR), link here a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today announced the appointment of a new Vice President of Business Development for its key markets outside of North America and Europe. Erin Wansbrough will lead Adherium’s partnering and market […]
CATEGORY: Featured Thursday, February 23, 2017 6:50 am EST – link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB “In 2017, AmpliPhi plans to initiate phage therapy studies in several patient groups, which we expect will mark a key inflection point for AmpliPhi and the phage therapy field” SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSE […]
DUBLIN, Ireland, Feb. 22, 2017 (GLOBE NEWSWIRE) –Link here Nexvet Biopharma (Nasdaq:NVET) today announced that its Chief Executive Officer, Dr. Mark Heffernan, is scheduled to present at the Cowen and Company 37th Annual Health Care Conference in Boston, Massachusetts on Monday, March 6th at 1:20PM ET. Dr. Heffernan will discuss Nexvet’s pivotal-stage clinical programs for […]
Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2017 – link here DUBLIN, Ireland, Feb. 10, 2017 (GLOBE NEWSWIRE) — Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three and six month periods ended December 31, 2016. Recent highlights: Initiated pivotal field efficacy and safety studies of frunevetmab, the Company’s anti-nerve […]
Posted in Mobile Health by Jamie Hartford on January 26, 2017 – link here The Smartinhaler system from New Zealand-based Adherium Ltd. connects with an app to monitor medication adherence, usage, and dosage. Daphne Allen The Smartinhaler system uses software to help providers gain insights about how patients use their medication. Smartinhaler, a “smart” personal medication monitoring system from Adherium Ltd., has shown effectiveness in reducing hospital […]